Abiraterone for Prostate Cancer Not Previously Treated with Hormone TherapyNicholas D. James, Matthew R. Sydes, Clare Gilson et al.|New England Journal of Medicine|2017Cited by 1.8k
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)Nicholas D. James, Jacob Tanguay, Noel W. Clarke et al.|International Journal of Cancer|2022Cited by 79
Plasma <i>AR</i> Alterations and Timing of Intensified Hormone Treatment for Prostate CancerGianmarco Leone, Francesco Orlando, Peter Dutey‐Magni et al.|JAMA Oncology|2025Cited by 5
UK real-world data of radium-223 dichloride in metastatic prostate cancerManreet Randhawa, Gail Buchanan, Irene Stratton et al.|Nuclear Medicine Communications|2025Cited by 1
A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate‐Resistant Prostate Cancer (TRICREST)Kenrick Ng, Jonathan Shamash, Garima Priyadarshini et al.|The Prostate|2025Cited by 0